PROK
ProKidney Corp.
1.60$
+0.0%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +1,075.0% | |
| – | – | – | +53.0% | +4.4% | – | – | |
| – | – | – | – | – | – | +1,075.0% | |
| – | -72.0% | +119.8% | +77.4% | +30.0% | +19.6% | -10.6% | |
| – | +36.3% | +56.2% | +701.1% | -36.8% | +25.1% | -7.7% | |
| – | -66.0% | +103.9% | +177.6% | -1.0% | +21.3% | -9.7% | |
| – | – | – | – | – | – | – | |
| – | – | -95.3% | +10,650.0% | -94.4% | -25.0% | -55.6% | |
| – | – | – | – | – | – | – | |
| – | -164.3% | – | +2,257.9% | +569.2% | -110.0% | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.